Results 11 to 20 of about 234 (97)

Метотрексат и ингибиторы протонной помпы – имеется ли негативное фармакологическое взаимодействие?

, 2014
Methotrexate (MTX) is the first-line medication to treat rheumatoid arthritis (RA). However, it may have serious adverse effects (AE) on liver, kidneys, hematopoietic system, etc., thus requiring meticulous control over patient’s condition and the ...
A. Е. Каратеев, A. A. Ermakova, Array N Berezyuk, Array S Solov’eva   +3 more
semanticscholar   +1 more source

Pharmacogenetics of proton pump inhibitors

Медицинский совет, 2015
Proton pump inhibitors (PPI) are currently the most effective class of antisecretory drugs widely used in the treatment of non-ulcer dyspepsia, reflux esophagitis and GERD, peptic ulcer disease and H. pilory infection, as well as NSAID-associated gastric
M. V. Leonova
doaj   +1 more source

Депрескрайбинг ингибиторов протонной помпы и выбор оптимального препарата данной группы (по результатам научного форума, состоявшегося в рамках XXVI Объединенной Российской гастроэнтерологической недели)

, 2020
Aim . Presentation of the Forum “Deprescribing and optimal selection of proton pump inhibitors” held in Moscow on 29 September 2020 during the 26th United Russian Gastroenterology Week. Key points .
Владимир Трофимович Ивашкин, Игорь Вениаминович Маев, А. С. Трухманов, Аркадий Александрович Шептулин, Владимир Ильич Симаненков, Т. Л. Лапина, И. Б. Хлынов, Наталья Николаевна Дехнич, О. Д. Лопина, О. П. Алексеева, Н. В. Корочанская, М. Ф. Осипенко, Павел Владимирович Павлов, С. С. Пирогов, Г. Н. Тарасова, Юрий Павлович Успенский, Дмитрий Николаевич Андреев, Д. Н. Румянцева   +17 more
semanticscholar   +1 more source

Prevention of gastrointestinal bleeding in patients receiving oral anticoagulants: focus on proton pump inhibitors

CARDIOVASCULAR THERAPY AND PREVENTION, 2019
The review addresses the issue of the gastrointestinal bleeding (GIB) development in patients receiving oral anticoagulants, and the proton pump inhibitors (PPIs) efficiency in reducing of such complications. Epidemiological data on the prevalence of GIB
желудочно-кишечных кровотечений, у пациентов, получающих, пероральные антикоагулянты, фокус на ингибиторы, протонной помпы   +5 more
semanticscholar   +1 more source

Diagnostics and treatment of peptic ulcer: clinical guidelines of the Russian gastroenterological Association

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2018
The aim of publication. To present modern concept on etiology and pathogenesis of the peptic ulcer (PUD) to general practitioners, to acquaint them with modern diagnostic methods and main treatment approaches of this disease. Summary.
V. T. Ivashkin, A. A. Sheptulin, I. V. Mayev, Ye. K. Baranskaya, A. S. Trukhmanov, T. L. Lapina, S. G. Burkov, A. V. Kalinin, A. V. Tkachev   +8 more
doaj   +1 more source

Pleiotropic effects of rabeprazole at acid-related diseases

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2018
Aim of investigation. To study association interleukin-1 (IL-1) gene (rs16944), interleukin-6 (IL-6) gene (rs1800795), interleukin-10 (IL-10) gene (rs1800896) polymorphisms with development of acute pancreatitis (AP) in the Russian population.
A. V. Zaborovsky, I. V. Mayev, D. N. Andreyev, L. A. Tararina   +3 more
doaj   +1 more source

Treatment compliance at initial and maintenance therapy at gastroesophageal reflux disease

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2018
Aim of investigation. To analyze treatment compliance at initial course and maintenance treatment by proton pump inhibitors at gastroesophageal reflux disease (GERD). Material and methods. Overall 84 GERD patients with took part in prospective study: 50 (
V. I. Simanenkov, S. V. Tikhonov, N. B. Lischuk   +2 more
doaj   +1 more source

Intravenous form of omeprazole will be replaced by oral form in patients with ulcer bleeding

, 2014
Результаты исследований свидетельствуют об одинаковой терапевтической эффективности пероральной и внутривенной форм омепразола у пациентов с язвенным кровотечением.
A. V. Savustyanenko
semanticscholar   +1 more source

Options for optimizing treatment of gastroesophageal reflux disease with proton pump inhibitors

Медицинский совет, 2015
Proton pump inhibitors (PPI) were successfully used for the treatment of acid-base disorders, in particular GERD, for the past 20 years. However, approximately 30% of patients with gastroesophageal reflux disease (GERD) do not adequately respond to ...
M. F. Osipenko, E. A. Bikbulatova, S. I. Kholin   +2 more
doaj   +1 more source

Current views on the problem of laryngopharyngeal reflux

Медицинский совет, 2015
The problem of LPR remains a challenge today: there is no clear definition of LPR, no single algorithm for the diagnosis or treatment of the disease. The article offers a current definition of LPR.
I. B. Angotoeva, A. A. Muldasheva
doaj   +1 more source